Acute hyponatremia and neuroleptic malignant syndrome in Parkinson's disease
- PMID: 8771607
- DOI: 10.1016/0278-5846(96)00015-2
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson's disease
Abstract
1. The neuroleptic malignant syndrome (NMS) may occur, occasionally, in Parkinson's disease (PD) after withdrawal of antiparkinsonian drugs. However, the circumstances in which the NMS occurs and the pathophysiologic mechanisms remain uncertain. 2. The authors studied a woman with PD, who developed hyperthermia, increased muscular tone, tremor, signs of autonomic dysfunction and stupor as symptoms of acute hyponatremia due to gastrointestinal loss of sodium in excess of water. 3. The correction of hyponatremia led to a complete recovery after about 6 hours. During this period the antiparkinsonian therapy was not modified. 4. An acute imbalance of sodium in the central nervous system may play a role in the pathophysiology of NMS.
Similar articles
-
Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period.Neurology. 1993 May;43(5):1048-9. doi: 10.1212/wnl.43.5.1048. Neurology. 1993. PMID: 7605396
-
Neuroleptic malignant syndrome in parkinsonian patients: risk factors.Eur Neurol. 1997;38 Suppl 2:56-9. doi: 10.1159/000113484. Eur Neurol. 1997. PMID: 9387804
-
Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.Intern Med. 1992 Nov;31(11):1298-302. doi: 10.2169/internalmedicine.31.1298. Intern Med. 1992. PMID: 1295627 Review.
-
Severe hyponatremia, neuroleptic malignant syndrome, rhabdomyolysis and acute renal failure: a case report.Mt Sinai J Med. 1998 Sep;65(4):284-8. Mt Sinai J Med. 1998. PMID: 9757749
-
[Neuroleptic malignant syndrome associated with the inadequate antidiuretic hormone secretion syndrome].Arch Neurobiol (Madr). 1992 Mar-Apr;55(2):75-8. Arch Neurobiol (Madr). 1992. PMID: 1352098 Review. Spanish.
Cited by
-
Malignant syndrome in Parkinson's disease without dopaminergic drug withdrawal.Ann Indian Acad Neurol. 2008 Oct;11(4):248-50. doi: 10.4103/0972-2327.44562. Ann Indian Acad Neurol. 2008. PMID: 19893683 Free PMC article.
-
Managing an effective treatment for neuroleptic malignant syndrome.Crit Care. 2007;11(1):R4. doi: 10.1186/cc5148. Crit Care. 2007. PMID: 17222339 Free PMC article. Review.
-
Neuroleptic malignant-like syndrome associated multiple system atrophy: report on three cases.BMC Neurol. 2022 Feb 25;22(1):67. doi: 10.1186/s12883-022-02583-8. BMC Neurol. 2022. PMID: 35216572 Free PMC article.
-
A Rare Case of Malignant Syndrome in Parkinson's Disease Caused by Severe Dehydration and Complicated by Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).Cureus. 2023 Jul 24;15(7):e42377. doi: 10.7759/cureus.42377. eCollection 2023 Jul. Cureus. 2023. PMID: 37621801 Free PMC article.
-
Malignant Syndrome in Parkinson Disease Similar to Severe Infection.Korean J Crit Care Med. 2017 Nov;32(4):359-362. doi: 10.4266/kjccm.2016.00087. Epub 2016 Dec 29. Korean J Crit Care Med. 2017. PMID: 31723658 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical